semaglutide iupac name Structure of semaglutide. The analog of human glucagon-like peptide-1 The Discovery and Development of

doi: 10.1093/asj/sjad211 [DOI] [PubMed] [Google Scholar] 6.Shao H, Li P, Guo J, Fonseca V, Shi L, Zhang P

concomitant drug use (one or more filled prescriptions before index), including individual covariates of metformin, sulfonylureas, combinations of non-metformin oral glucose-lowering drugs, -glucosidase inhibitors, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, sodiumglucose co-transporter 2 inhibitors, other blood glucose-lowering drugs, statins, aspirin, non-aspirin non-steroidal anti-inflammatory drugs, antihypertensives, other cardiovascular drugs, 5-reductase inhibitors or psychotropic drugs

Resveratrol, metabolic syndrome, and gut microbiota

GLP-1 medications are associated with dose-dependent side effects, particularly gastrointestinal symptoms

Aging and Disease, 12 (8), 20962112